{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T22:44:58Z","timestamp":1774133098418,"version":"3.50.1"},"reference-count":21,"publisher":"American Veterinary Medical Association (AVMA)","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["javma"],"published-print":{"date-parts":[[2022,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:p>Occult feline hypertrophic cardiomyopathy (HCM) can result in unexpected sudden death or congestive heart failure (CHF) following routine interventions such as anesthesia, fluid administration, or, potentially, administration of corticosteroids. Consequently, clinicians would like to be able to screen at-risk cats to detect occult HCM and either avoid the risky intervention or attempt to reduce the risk of death or CHF. Currently, the feline N-terminal-proBrain natriuretic peptide test is the only potential screening test for detecting occult HCM. However, some cardiologists have pointed out the poor sensitivity of the test precludes its use as a screening test. This interpretation appears somewhat flawed. Using the current rapid test will allow clinicians to correctly identify half of the cats with moderate-to-severe occult HCM. A small number of cats without HCM will also test positive, necessitating an ultimately needless echocardiographic evaluation to demonstrate their disease-free status. However, the low prevalence of HCM in the general cat population and the apparently much lower rate of adverse events than would be predicted brings into question whether clinicians should bother screening. Therefore, until a more sensitive and accurate screening test becomes available, clinicians will have to decide for themselves whether identifying half of the at-risk cats of sudden death and CHF with this test is better than identifying none of them.<\/jats:p>","DOI":"10.2460\/javma.22.06.0257","type":"journal-article","created":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T18:49:50Z","timestamp":1659034190000},"page":"1626-1630","source":"Crossref","is-referenced-by-count":2,"title":["Should we be screening cats for cardiomyopathy? If so, how?"],"prefix":"10.2460","volume":"260","author":[{"given":"Mark","family":"Rishniw","sequence":"first","affiliation":[{"name":"Veterinary Information Network, Davis, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1272","reference":[{"issue":"4","key":"ref1","series-title":"J Vet Intern Med","first-page":"1663","article-title":"Point-of-care N-terminal pro B-type natriuretic peptide assay to screen apparently healthy cats for cardiac disease in general practice","volume":"35","author":"Lu TL","year":"2021","unstructured":"Lu TL, C\u00f4t\u00e9 E, Kuo YW,  Point-of-care N-terminal pro B-type natriuretic peptide assay to screen apparently healthy cats for cardiac disease in general practice. J Vet Intern Med. 2021;35(4):1663\u20131672. doi:10.1111\/JVIM.1615633993546"},{"issue":"11","key":"ref2","series-title":"J Feline Med Surg","first-page":"1028","article-title":"The feline cardiomyopathies: 2. hypertrophic cardiomyopathy","volume":"23","author":"Kittleson MD","year":"2021","unstructured":"Kittleson MD, C\u00f4t\u00e9 E. The feline cardiomyopathies: 2. hypertrophic cardiomyopathy. J Feline Med Surg. 2021;23(11):1028\u20131051. doi:10.1177\/1098612X21102016234693811"},{"issue":"3","key":"ref3","series-title":"Int J Appl Res Vet Med","first-page":"159","article-title":"Corticosteroid-associated congestive heart failure in 12 cats","volume":"2","author":"Smith SA","year":"2004","unstructured":"Smith SA, Tobias AH, Fine DM, Jacob KA, Ployngam T. Corticosteroid-associated congestive heart failure in 12 cats. Int J Appl Res Vet Med. 2004;2(3):159\u2013170."},{"issue":"2","key":"ref4","series-title":"J Am Vet Med Assoc","first-page":"202","article-title":"Population and survival characteristics of cats with hypertrophic cardiomyopathy: 260 cases (1990\u20131999)","volume":"220","author":"Rush JE","year":"2002","unstructured":"Rush JE, Freeman LM, Fenollosa NK, Brown DJ. Population and survival characteristics of cats with hypertrophic cardiomyopathy: 260 cases (1990\u20131999). J Am Vet Med Assoc. 2002;220(2):202\u2013207. doi:10.2460\/javma.2002.220.20212126131"},{"issue":"3","key":"ref5","series-title":"J Vet Intern Med","first-page":"930","article-title":"International collaborative study to assess cardiovascular risk and evaluate long-term health in cats with preclinical hypertrophic cardiomyopathy and apparently healthy cats: The REVEAL Study","volume":"32","author":"Fox PR","year":"2018","unstructured":"Fox PR, Keene BW, Lamb K,  International collaborative study to assess cardiovascular risk and evaluate long-term health in cats with preclinical hypertrophic cardiomyopathy and apparently healthy cats: The REVEAL Study. J Vet Intern Med. 2018;32(3):930\u2013943. doi:10.1111\/JVIM.1512229660848"},{"issue":"6","key":"ref6","series-title":"J Vet Intern Med","first-page":"1427","article-title":"Prognostic Indicators in Cats with Hypertrophic Cardiomyopathy","volume":"27","author":"Payne JRR","year":"2013","unstructured":"Payne JRR, Borgeat K, Connolly DJJ,  Prognostic Indicators in Cats with Hypertrophic Cardiomyopathy. J Vet Intern Med. 2013;27(6):1427\u20131436. doi:10.1111\/jvim.1221524134821"},{"key":"ref7","series-title":"J Vet Cardiol","first-page":"S318","article-title":"Risk factors associated with sudden death vs. congestive heart failure or arterial thromboembolism in cats with hypertrophic cardiomyopathy","volume":"17","author":"Payne JR","year":"2015","unstructured":"Payne JR, Borgeat K, Brodbelt DC, Connolly DJ, Fuentes VL. Risk factors associated with sudden death vs. congestive heart failure or arterial thromboembolism in cats with hypertrophic cardiomyopathy. J Vet Cardiol. 2015;17(suppl 1):S318\u2013S328. doi:10.1016\/j.jvc.2015.09.008"},{"key":"ref8","series-title":"J Vet Cardiol","first-page":"S244","article-title":"Cardiomyopathy prevalence in 780 apparently healthy cats in rehoming centres (the CatScan study)","volume":"17","author":"Payne JR","year":"2015","unstructured":"Payne JR, Brodbelt DC, Luis Fuentes V. Cardiomyopathy prevalence in 780 apparently healthy cats in rehoming centres (the CatScan study). J Vet Cardiol. 2015;17(suppl 1):S244\u2013S257. doi:10.1016\/j.jvc.2015.03.00826776583"},{"issue":"11","key":"ref9","series-title":"J Am Vet Med Assoc","first-page":"1398","article-title":"Prevalence of cardiomyopathy in apparently healthy cats","volume":"234","author":"Paige CF","year":"2009","unstructured":"Paige CF, Abbott JA, Elvinger F, Pyle RL. Prevalence of cardiomyopathy in apparently healthy cats. J Am Vet Med Assoc. 2009;234(11):1398\u20131403. doi:10.2460\/javma.234.11.139819480619"},{"issue":"3","key":"ref10","series-title":"J Am Vet Med Assoc","first-page":"384","article-title":"Assessment of the prevalence of heart murmurs in overtly healthy cats","volume":"225","author":"C\u00f4t\u00e9 E","year":"2004","unstructured":"C\u00f4t\u00e9 E, Manning AM, Emerson D, Laste NJ, Malakoff RL, Harpster NK. Assessment of the prevalence of heart murmurs in overtly healthy cats. J Am Vet Med Assoc. 2004;225(3):384\u2013388. doi:10.2460\/javma.2004.225.38415328713"},{"key":"ref11","series-title":"J Vet Cardiol","first-page":"S134","article-title":"Screening for hypertrophic cardiomyopathy in cats","volume":"17","author":"H\u00e4ggstr\u00f6m J","year":"2015","unstructured":"H\u00e4ggstr\u00f6m J, Luis Fuentes V, Wess G. Screening for hypertrophic cardiomyopathy in cats. J Vet Cardiol. 2015;17(suppl 1):S134\u2013S149. doi:10.1016\/j.jvc.2015.07.00326776573"},{"issue":"4","key":"ref12","series-title":"J Vet Intern Med","first-page":"709","article-title":"Diagnostic accuracy of electrocardiography and thoracic radiography in the assessment of left atrial size in cats: comparison with transthoracic 2-dimensional echocardiography","volume":"21","author":"Schober KE","year":"2007","unstructured":"Schober KE, Maerz I, Ludewig E, Stern JA. Diagnostic accuracy of electrocardiography and thoracic radiography in the assessment of left atrial size in cats: comparison with transthoracic 2-dimensional echocardiography. J Vet Intern Med. 2007;21(4):709\u2013718. doi:10.1892\/0891-6640(2007)21[709:daoeat]2.0.co;217708390"},{"key":"ref13","series-title":"J Vet Cardiol","first-page":"S87","article-title":"Thoracic radiography in the cat: identification of cardiomegaly and congestive heart failure","volume":"17","author":"Guglielmini C","year":"2015","unstructured":"Guglielmini C, Diana A. Thoracic radiography in the cat: identification of cardiomegaly and congestive heart failure. J Vet Cardiol. 2015;17(suppl 1):S87\u2013S101. doi:10.1016\/j.jvc.2015.03.00526776597"},{"issue":"4","key":"ref14","series-title":"J Vet Cardiol","first-page":"245","article-title":"Multi-centered investigation of a point-of-care NT-proBNP ELISA assay to detect moderate to severe occult (preclinical) feline heart disease in cats referred for cardiac evaluation","volume":"16","author":"Machen MC","year":"2014","unstructured":"Machen MC, Oyama MA, Gordon SG,  Multi-centered investigation of a point-of-care NT-proBNP ELISA assay to detect moderate to severe occult (preclinical) feline heart disease in cats referred for cardiac evaluation. J Vet Cardiol. 2014;16(4):245\u2013255. doi:10.1016\/j.jvc.2014.09.00225456274"},{"issue":"2","key":"ref15","series-title":"Vet Clin Pathol","first-page":"237","article-title":"Utility of measuring plasma N-terminal pro-brain natriuretic peptide in detecting hypertrophic cardiomyopathy and differentiating grades of severity in cats","volume":"40","author":"Wess G","year":"2011","unstructured":"Wess G, Daisenberger P, Mahling M, Hirschberger J, Hartmann K. Utility of measuring plasma N-terminal pro-brain natriuretic peptide in detecting hypertrophic cardiomyopathy and differentiating grades of severity in cats. Vet Clin Pathol. 2011;40(2):237\u2013244. doi:10.1111\/j.1939-165X.2011.00305.x21434959"},{"issue":"16","key":"ref16","series-title":"N Engl J Med","first-page":"1579","article-title":"Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer","volume":"357","author":"Mayrand M-H","year":"2007","unstructured":"Mayrand M-H, Duarte-Franco E, Rodrigues I,  Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med. 2007;357(16):1579\u20131588. doi:10.1056\/NEJMoa07143017942871"},{"issue":"2","key":"ref17","series-title":"Indian J Surg Oncol","first-page":"120","article-title":"A review on the clinical utility of PSA in cancer prostate","volume":"3","author":"Adhyam M","year":"2012","unstructured":"Adhyam M, Gupta AK. A review on the clinical utility of PSA in cancer prostate. Indian J Surg Oncol. 2012;3(2):120\u2013129. doi:10.1007\/s13193-012-0142-623730101"},{"issue":"5","key":"ref18","series-title":"Br J Anaesth","first-page":"617","article-title":"Risk factors for anaesthetic-related death in cats: results from the confidential enquiry into perioperative small animal fatalities (CEPSAF)","volume":"99","author":"Brodbelt DC","year":"2007","unstructured":"Brodbelt DC, Pfeiffer DU, Young LE, Wood JLN. Risk factors for anaesthetic-related death in cats: results from the confidential enquiry into perioperative small animal fatalities (CEPSAF). Br J Anaesth. 2007;99(5):617\u2013623. doi:10.1093\/bja\/aem22917881744"},{"key":"ref19","series-title":"Vet J","first-page":"11","article-title":"Perioperative mortality in cats and dogs undergoing spay or castration at a high-volume clinic","volume":"224","author":"Levy JK","year":"2017","unstructured":"Levy JK, Bard KM, Tucker SJ, Diskant PD, Dingman PA. Perioperative mortality in cats and dogs undergoing spay or castration at a high-volume clinic. Vet J. 2017;224:11\u201315. doi:10.1016\/j.tvjl.2017.05.01328697869"},{"issue":"7","key":"ref20","series-title":"Arch Intern Med","first-page":"1257","article-title":"The \u201cchagrin factor\u201d and qualitative decision analysis","volume":"145","author":"Feinstein AR","year":"1985","unstructured":"Feinstein AR. The \u201cchagrin factor\u201d and qualitative decision analysis. Arch Intern Med. 1985;145(7):1257\u20131259."},{"issue":"1","key":"ref21","series-title":"BMC Fam Pract","first-page":"57","article-title":"Regret among primary care physicians: a survey of diagnostic decisions","volume":"21","author":"M\u00fcller BS","year":"2020","unstructured":"M\u00fcller BS, Donner-Banzhoff N, Beyer M, Haasenritter J, M\u00fcller A, Seifart C. Regret among primary care physicians: a survey of diagnostic decisions. BMC Fam Pract. 2020;21:(1);57. doi:10.1186\/s12875-020-01125-w"}],"container-title":["Journal of the American Veterinary Medical Association"],"original-title":[],"link":[{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/javma\/260\/13\/javma.22.06.0257.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/javma\/260\/13\/javma.22.06.0257.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/javma\/260\/13\/javma.22.06.0257.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T12:59:19Z","timestamp":1741352359000},"score":1,"resource":{"primary":{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/javma\/260\/13\/javma.22.06.0257.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,1]]},"references-count":21,"journal-issue":{"issue":"13"},"URL":"https:\/\/doi.org\/10.2460\/javma.22.06.0257","relation":{},"ISSN":["0003-1488"],"issn-type":[{"value":"0003-1488","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,1]]}}}